Education
About Us
Working with TipRanks
Follow Us
Sands Capital Life Sciences Pulse Fund II, L.P. Insider Profile
4 Followers
Sands Capital Life Sciences Pulse Fund II, L.P., Ten Percent Owner at Inhibikase Therapeutics, holds 13.02M shares in Inhibikase Therapeutics (Ticker: IKT). Most recently, Sands Capital Life Sciences Pulse Fund II, L.P. Bought 2,068,965 shares of Inhibikase Therapeutics on Nov 24, 2025 for an estimated value of $3.00M.
Sands Capital Life Sciences Pulse Fund II, L.P. Inhibikase Therapeutics (IKT)Ten Percent Owner
Inhibikase Therapeutics (IKT)
Ten Percent Owner
Not Ranked
Sands Capital Life Sciences Pulse Fund II, L.P. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Sands Capital Life Sciences Pulse Fund II, L.P.'s holdings
Insider Roles
Ten Percent Owner
Roles that Sands Capital Life Sciences Pulse Fund II, L.P. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Sands Capital Life Sciences Pulse Fund II, L.P.
Sands Capital Life Sciences Pulse Fund II, L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see Sands Capital Life Sciences Pulse Fund II, L.P.'s performance on stock
You May Also Like
Sands Capital Life Sciences Pulse Fund II, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Sands Capital Life Sciences Pulse Fund II, L.P.?
The percentage of profitable transactions made by Sands Capital Life Sciences Pulse Fund II, L.P. is ―.
What is the average return per transaction made by Sands Capital Life Sciences Pulse Fund II, L.P.?
The average return per transaction made by Sands Capital Life Sciences Pulse Fund II, L.P. is ―.
What stocks does Sands Capital Life Sciences Pulse Fund II, L.P. hold?
Sands Capital Life Sciences Pulse Fund II, L.P. holds: IKT stocks.
What was Sands Capital Life Sciences Pulse Fund II, L.P.’s latest transaction?
Sands Capital Life Sciences Pulse Fund II, L.P. latest transaction was an Informative Buy of $3.00M.
What was Sands Capital Life Sciences Pulse Fund II, L.P.'s most profitable transaction?
Sands Capital Life Sciences Pulse Fund II, L.P.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Sands Capital Life Sciences Pulse Fund II, L.P.'s role in Inhibikase Therapeutics?
Sands Capital Life Sciences Pulse Fund II, L.P.'s role in Inhibikase Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.